You are here

Novartis

CEO interrupted: Novartis chief Narasimhan looks to new ethics czar to clean up after the lingering Cohen mess

CEO interrupted: Novartis chief Narasimhan looks to new ethics czar to clean up after the lingering Cohen mess

Endpoints

Vasant Narasimham

Flag link:

Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies

Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies

Fierce Pharma

Flag link:

Racing Novartis on Eylea rival, the FDA trips up Regeneron at the finish line

Racing Novartis on Eylea rival, the FDA trips up Regeneron at the finish line

Endpoints

wet age-related macular degeneration

Flag link:

Why Novartis Stock Gained 11% in July

Why Novartis Stock Gained 11% in July

Motley Fool

Flag link:

Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech

Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech

Fierce Biotech

Flag link:

pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in

pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in

RAPS.org

Gilead Sciences

drug-drug interactions

proton pump inhibitors

Flag link:

Omeros Prevails in Patent Dispute With Sandoz

Omeros Prevails in Patent Dispute With Sandoz

CP Wire

Flag link:

Months after IPO, Novartis spinout resTORbio wins on PhIIb data — stock soars

Months after IPO, Novartis spinout resTORbio wins on PhIIb data — stock soars

Endpoints

Flag link:

Kymriah Manufacturing Issues Spell Trouble for Commercialization of Novartis CAR-T Therapy

Kymriah Manufacturing Issues Spell Trouble for Commercialization of Novartis CAR-T Therapy

Xtalks

drug manufacturing

Flag link:

Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices

Roche has taken the Trump pledge, joining Pfizer, Novartis and Merck in promising to hold the line on drug prices

Endpoints

Flag link:

Trump thanks Novartis, Pfizer for not raising drug prices

Trump thanks Novartis, Pfizer for not raising drug prices

Yahoo/Reuters

Flag link:

Novartis to Pay as Much as $1 Billion for Rights to Skin Drug

Novartis to Pay as Much as $1 Billion for Rights to Skin Drug

Yahoo/Bloomberg

atopic dermatitis

Flag link:

Novartis' MS patent win also a win for Celgene's impending MS drug: analyst

Novartis' MS patent win also a win for Celgene's impending MS drug: analyst

Medical Marketing and Media

multiple sclerosis

Flag link:

FDA Approves First Cancer Drug Under New Real Time Review Program

FDA Approves First Cancer Drug Under New Real Time Review Program

CP Wire

Real Time Oncology Review

Flag link:

Novartis Reports Growth in Q2 2018 Earnings

Novartis Reports Growth in Q2 2018 Earnings

Market Realist

Flag link:

Under the gun for Cohen deal, Novartis CEO Vas Narasimhan hits the brakes on US drug price hikes

Under the gun for Cohen deal, Novartis CEO Vas Narasimhan hits the brakes on US drug price hikes

Endpoints

Flag link:

Is a Surprise in the Cards for Novartis in Q2 Earnings?

Is a Surprise in the Cards for Novartis in Q2 Earnings?

Yahoo/Zacks.com

Flag link:

Novartis, Michael Cohen contacts were more extensive than previously disclosed

Novartis, Michael Cohen contacts were more extensive than previously disclosed

Stat

Flag link:

MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too

MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too

Fierce Pharma

Flag link:

Novartis partners with French CDMO to bolster CAR-T supply

Novartis partners with French CDMO to bolster CAR-T supply

Biopharma Dive

Flag link:

Pages